With contributions on parallel imports, pharmaceutical trademarks, combination products and the SPC manufacturing waiver, EPLR 3/2019 tracks some of the most important legal and regulatory developments in the pharmaceutical sector.

As usual, the issue also includes brief updates on recent judgements and policy changes.

View the whole table of contents: here.